Some people notice mild changes in hunger patterns within 24-72 hours of the first injection
Many people are looking to build muscle on GLP-1 as part of a healthier, stronger lifestyle
While these medications arent approved for chronic inflammatory diseases such as rheumatoid arthritis (RA), many people with RA have been prescribed a GLP-1 to manage a coexisting condition
Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
A wide range of individuals might find semaglutide GLP-1 injections beneficial as part of a comprehensive medical weight loss strategy
doi:10.1177/10600280251407145